GHK
Research onlyAlso known as: glycyl-l-histidyl-l-lysine, 49557-75-7, Prezatide, Liver cell growth factor, Glycyl-histidyl-lysine, Copper(II)ghk, KOLLAREN, ORISTAR GHK
GHK (glycyl-l-histidyl-l-lysine, 49557-75-7, Prezatide) is classified under copper & cosmetic signal peptides, sold for research use only and not approved for human consumption.
Read the full guide: what the research shows on GHK →What the research says
Aggregated from the cited literature below. We summarize sources — we don't author claims.
GHK (glycyl-L-histidyl-lysine; aliases include glycyl-histidyl-lysine and copper(II) GHK) is described in the provided sources as a naturally occurring tripeptide that declines with age and has been investigated for multiple regeneration-, anti-inflammatory-, antioxidant-, and anti-aging–related actions. Multiple papers focus on its affinity for copper and formation of a GHK-Cu chelate, as well as on skin-/tissue-repair–related pathway modulation and delivery/formulation studies.
Mechanism (as reported)
Across the provided sources, GHK is repeatedly discussed as acting through copper binding (forming GHK-Cu) and as modulating pathways related to wound healing and tissue remodeling. A review also describes effects on collagen/glycosaminoglycan metabolism and metalloproteinase balance, as well as gene-regulatory effects described as modulating large numbers of human genes. One study/composition paper describes interactions of GHK-presenting liposomes with heparin and reports changes consistent with altered cell-penetrating behavior and reduced oxidative stress readouts in an in vitro oxidative-stress context. (Mechanistic details vary by paper.)
Key findings (each cites a source)
- A study/review reported that GHK has multiple biological actions including stimulation of blood vessel and nerve outgrowth, increased collagen/elastin/glycosaminoglycan synthesis, and support of dermal fibroblast function; it also reported tissue-repair and cell-protective actions across multiple organ/tissue contexts (including skin, lung connective tissue, bone, liver, and stomach lining) and described diverse anti-cancer/anti-inflammatory and other protective activities attributed to GHK, with genetic data used to explain multiple regulated pathways. [PMID 29986520]
- Research described GHK and its high-affinity copper chelate (GHK-Cu) as having anti-inflammatory and tissue remodeling properties, with reported antioxidant and anti-inflammatory effects and reported GHK-Cu–associated skin remodeling and wound healing/regeneration in in vitro and in vivo studies; the same source also mentioned preliminary observations in aging mice related to partial reversal of cognitive impairment via anti-inflammatory and epigenetic pathways and proposed further preclinical/clinical aging investigation. [PMID 35083444]
- A review focused on topical anti-wrinkle use reported that GHK is broadly promoted for topical application and described capabilities related to tissue regeneration, enhancement of collagen and glycosaminoglycan synthesis, and increases in nerve outgrowth and angiogenesis; it further noted that published clinical studies using GHK-Cu and Pal-GHK were absent/surprisingly lacking and that information on skin permeability and other physicochemical aspects was insufficient. [PMID 39963574]
- A skin-regeneration-focused review described GHK as present in human plasma/saliva/urine and proposed copper 2+ complex formation as part of its wound-healing/skin-repair function; it also reported that GHK stimulates collagen and glycosaminoglycan synthesis and modulates metalloproteinases and their inhibitors, including upregulation of specific matrix components (e.g., decorin and dermatan/chondroitin sulfate) and reported multiple tissue contexts for wound-healing observations, along with proposed roles in skin inflammation, COPD, and metastatic colon cancer. [PMID 26236730]
- An in vivo study reported that GHK prevented acute learning impairment in sleep-deprived aging mice and described that GHK-treated sleep-deprived mice did not show increases in hippocampal MCP-1 and nitrotyrosine levels, which the study linked to inflammatory and reactive nitrogen/oxygen species activity. [PMID 37035833]
- A commentary described that GHK reverses age-related fibrosis by modulating myofibroblast function, including reversing cellular senescence and inducing apoptosis in myofibroblasts, and described effects on regeneration/wound healing via stemness markers and possible restoration of youthful phenotypes in pulmonary fibroblasts; it also discussed integrin-β1 signaling as part of the molecular discussion. [PMID 40823151]
Independent test grades
No independent third-party test data is available for GHK yet. Our test grades are aggregated from Finnrick, which independently tests a subset of research peptides — many approved drugs and newer or niche compounds aren't covered.
Research literature (9)
Consolidated from PubMed — each links to the original record.
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.
Mayfield CK, Bolia IK, Feingold CL, Lin EH, Liu JN, Rick Hatch GF · The American journal of sports medicine · 2026 · PMID 41476424
- Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective.
Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR · BioImpacts : BI · 2025 · PMID 39963574
- Evaluation of GHK peptide-heparin interactions in multifunctional liposomal covering.
Nikolaeva V, Kamalov M, Abdullin TI, Salakhieva D, Chasov V, Rogov A · Journal of liposome research · 2024 · PMID 37144381
- The naturally occurring peptide GHK reverses age-related fibrosis by modulating myofibroblast function.
He Q, Mazzola J, Ladiges W · Aging pathobiology and therapeutics · 2024 · PMID 40823151
- GHK peptide prevents sleep-deprived learning impairment in aging mice.
Rosenfeld M, Nickel K, Ladiges W · Aging pathobiology and therapeutics · 2023 · PMID 37035833
- Biologic Therapies for Severe Asthma.
Brusselle GG, Koppelman GH · The New England journal of medicine · 2022 · PMID 35020986
- The potential of GHK as an anti-aging peptide.
Dou Y, Lee A, Zhu L, Morton J, Ladiges W · Aging pathobiology and therapeutics · 2020 · PMID 35083444
FAQ
- What is GHK?
- GHK (glycyl-l-histidyl-l-lysine, 49557-75-7, Prezatide) is classified under copper & cosmetic signal peptides, sold for research use only and not approved for human consumption. Research goals associated with it include recovery & tissue repair, skin, hair & pigmentation.
- Is GHK FDA-approved?
- No. GHK is sold for research use only and is not approved for human consumption.
- What does the research on GHK say?
- peptideone aggregates 9 references from PubMed for GHK. The summary on this page digests them with citations; we summarize sources and make no efficacy claims.